The Filing Desk

HeartFlow vs OptimizeRx

HeartFlow HTFL · OptimizeRx OPRX · Health Care Technology

HeartFlow reported revenue of $176 million in fiscal 2025, 1.6 times OptimizeRx's $109 million in fiscal 2025. HeartFlow's revenue grew 39.9% in its latest year, and OptimizeRx's grew 18.8%. HeartFlow had an operating margin of -36.4%, against 10.7% at OptimizeRx. Free cash flow was −$59 million at HeartFlow and $19 million at OptimizeRx.

Side by side

HeartFlowOptimizeRx
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$176M$109M
Revenue growth39.9%18.8%
Revenue growth a year, last 5 years—20.4%
Gross margin76.8%67.2%
Operating margin−36.4%10.7%
Net margin−66.3%4.7%
Free cash flow−$59M$19M
Free cash flow margin−33.5%17.1%
Return on capital—6.4%
Net debt to EBITDA—0.2x
Dividends and buybacks$0M$0M
Change in diluted share count587.1%3.9%
Last close$44.63$7.01
P/E at the last close—28.0×
Insider trades, last 12 monthsbought $1.1 million, sold $142.3 millionsold $18,752
Piotroski F-score—8 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
HeartFlowOptimizeRx
Operating margin
Percent of revenue
HeartFlowOptimizeRx
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
HeartFlowOptimizeRx

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the HeartFlow and OptimizeRx pages.